QNova LifeSciences

QNova LifeSciences combines regulatory, clinical, strategy and commercialization support for emerging and established life-sciences companies. It guides drugs and devices through development planning, FDA interactions, submissions, quality systems, medical writing, clinical execution and US market entry. The organization rebranded from CSSi LifeSciences to QNova LifeSciences in April 2025.